Mulligan Therapy Effects In Healthy Subjects With Induced Vertigo
NCT ID: NCT05118659
Last Updated: 2021-11-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2018-02-03
2018-06-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SNAG GROUP
The SNAG group received a treatment based on sustained apophyseal glides in a postero-anterior direction on C2 with a dose of three series of ten repetitions each, combined with active cervical extension.
sustained natural apophyseal glides
It consists on a sustained apophyseal glides in a postero-anterior direction on C2 with a dose of three series of ten repetitions each
SHAM SNAG GROUP
The placebo SNAG group received a simulation of the contact used for the SNAGs, without any vertebral glide, and with an active cervical extension.
SHAM SNAG
Subjects on SNAG group received a simulation of the contact used for the SNAGs, without any vertebral glide, and with an active cervical extension
CONTROL GROUP
The control group did not receive any type of intervention, they only waited for four minutes, sat down on a chair
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
sustained natural apophyseal glides
It consists on a sustained apophyseal glides in a postero-anterior direction on C2 with a dose of three series of ten repetitions each
SHAM SNAG
Subjects on SNAG group received a simulation of the contact used for the SNAGs, without any vertebral glide, and with an active cervical extension
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18-44 years.
Exclusion Criteria
* Hippoacusia
* Auditory diseases
* Peripheral or central vestibulopathies
* Cerviogenic dizziness
* Balance disorders
* Nistagmus
* Oculomotor nerve dysfunctions
* Migraine
* Cervical osteoporosis, lashing or fracture
* Discal cervical hernia
* Cervical neuropathy
* Psychriatic disorders
* Epilepsy
* Pregnancy
18 Years
44 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centro Universitario La Salle
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jose Vicente Leon Hernandez
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CSEU La Salle
Madrid, , Spain
Jose V Leon Hernandez
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CSEULS-PI-198/2018
Identifier Type: -
Identifier Source: org_study_id